Table of Contents
ISRN Endocrinology
Volume 2012 (2012), Article ID 691803, 5 pages
http://dx.doi.org/10.5402/2012/691803
Clinical Study

The Association of Hypovitaminosis D with the Metabolic Syndrome Is Independent of the Degree of Obesity

1Endocrinology and Nutrition Department, Hospital de la Santa Creu i Sant Pau, Sant Antoni Maria Claret 167, 08025 Barcelona, Spain
2Medicine Department, Universitat Autònoma de Barcelona (UAB), 08193 Bellaterra, Spain
3Diabetes and Metabolic Diaseases CIBER, CIBERDEM, Sant Antoni maria Claret 167, 08025 Barcelona, Spain
4Biomedical Research Institute (IIB Sant Pau), Sant Antoni Maria Claret 167, 08025 Barcelona, Spain
5Clinical Biochemistry Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona (UAB), Sant Antoni Maria Claret 167, 08025 Barcelona, Spain
6Bioengineering, Biomaterials and Nanomedicine CIBER, CIBERBBN, Sant Antoni Maria Claret 167, 08025 Barcelona, Spain

Received 6 September 2012; Accepted 23 September 2012

Academic Editors: E. Blázquez, T. W. Furlanetto, G. Garruti, and J. Vrbikova

Copyright © 2012 Inka Miñambres et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Martins, M. Wolf, D. Pan et al., “Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the third national health and nutrition examination survey,” Archives of Internal Medicine, vol. 167, no. 11, pp. 1159–1165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. L. Vacek, S. R. Vanga, M. Good et al., “Vitamin D deficiency and supplementation and relation to cardiovascular health,” American Journal of Cardiology, vol. 109, no. 3, pp. 359–363, 2012. View at Google Scholar
  3. S. D. H. Malnick and H. Knobler, “The medical complications of obesity,” QJM: An International Journal of Medicine, vol. 99, no. 9, pp. 565–579, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. J. E. Compston, S. Vedi, J. E. Ledger et al., “Vitamin D status and bone histomorphometry in gross obesity,” American Journal of Clinical Nutrition, vol. 34, no. 11, pp. 2359–2363, 1981. View at Google Scholar · View at Scopus
  5. M. B. Snijder, R. M. Van Dam, M. Visser et al., “Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 7, pp. 4119–4123, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Kamycheva, J. Sundsfjord, and R. Jorde, “Serum parathyroid hormone level is associated with body mass index. The 5th Tromsø study,” European Journal of Endocrinology, vol. 151, no. 2, pp. 167–172, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Ybarra, J. Sánchez-Hernández, I. Gich et al., “Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery,” Obesity Surgery, vol. 15, no. 3, pp. 330–335, 2005. View at Google Scholar · View at Scopus
  8. The Practical Guide Identification, Evaluation, and Treatment of Overweight and Obesity in Adults, National Institutes of Health, Bethesda, Md, USA, 2000.
  9. S. M. Grundy, J. I. Cleeman , S. R. Daniels et al., “Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement,” Circulation, vol. 112, no. 17, pp. 2735–2752, 2005. View at Google Scholar
  10. P. Lips, “Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications,” Endocrine Reviews, vol. 22, no. 4, pp. 477–501, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Wortsman, L. Y. Matsuoka, T. C. Chen, Z. Lu, and M. F. Holick, “Decreased bioavailability of vitamin D in obesity,” American Journal of Clinical Nutrition, vol. 72, no. 3, pp. 690–693, 2000. View at Google Scholar · View at Scopus
  12. C. P. Earthman, L. M. Beckman, K. Masodkar, and S. D. Sibley, “The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications,” International Journal of Obesity, vol. 36, no. 3, pp. 387–396, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. M. Carlin, D. S. Rao, A. M. Meslemani et al., “Prevalence of vitamin D depletion among morbidly obese patients seeking gastric bypass surgery,” Surgery for Obesity and Related Diseases, vol. 2, no. 2, pp. 98–103, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. E. S. Ford, U. A. Ajani, L. C. McGuire, and S. Liu, “Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults,” Diabetes Care, vol. 28, no. 5, pp. 1228–1230, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. P. Reis, D. Von Mühlen, and E. R. Miller, “Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults,” European Journal of Endocrinology, vol. 159, no. 1, pp. 41–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Muldowney, A. J. Lucey, G. Paschos et al., “Relationships between vitamin D status and cardio-metabolic risk factors in young European adults,” Annals of Nutrition and Metabolism, vol. 58, no. 2, pp. 85–93, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. D. M. Lee, M. K. Rutter, T. W. O'Neill et al., “Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men,” European Journal of Endocrinology, vol. 161, no. 6, pp. 947–954, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. N. G. Forouhi, J. Luan, A. Cooper, B. J. Boucher, and N. J. Wareham, “Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance the medical research council ely prospective study 1990–2000,” Diabetes, vol. 57, no. 10, pp. 2619–2625, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Hyppönen, B. J. Boucher, D. J. Berry, and C. Power, “25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age A cross-sectional study in the 1958 British Birth Cohort,” Diabetes, vol. 57, no. 2, pp. 298–305, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. K. Kim, M. Il Kang, K. Won Oh et al., “The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects,” Clinical Endocrinology, vol. 73, no. 3, pp. 330–338, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. F. M. Moy and A. Bulgiba, “High prevalence of vitamin D insufficiency and its association with obesity and metabolic syndrome among Malay adults in Kuala Lumpur, Malaysia,” BMC Public Health, vol. 11, artricle 735, 2011. View at Google Scholar
  22. L. Pacifico, C. Anania, J. F. Osborn et al., “Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents,” European Journal of Endocrinology, vol. 165, no. 4, pp. 603–611, 2011. View at Google Scholar
  23. V. Ganji, X. Zhang, N. Shaikh, and V. Tangpricha, “Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001–2006,” American Journal of Clinical Nutrition, vol. 94, no. 1, pp. 225–233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. J. P. Reis, D. Von Mühlen, E. R. Miller, E. D. Michos, and L. J. Appel, “Vitamin D status and cardiometabolic risk factors in the United States adolescent population,” Pediatrics, vol. 124, no. 3, pp. e371–e379, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. A. Chacko, Y. Song, J. E. Manson et al., “Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women,” American Journal of Clinical Nutrition, vol. 94, no. 1, pp. 209–217, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Rueda, C. Fernández-Fernández, F. Romero, M. J. Martínez de Osaba, and J. Vidal, “Vitamin D, PTH, and the metabolic syndrome in severely obese subjects,” Obesity Surgery, vol. 18, no. 2, pp. 151–154, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Hjelmesæth, D. Hofsø, E. T. Aasheim et al., “Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study,” Cardiovascular Diabetology, vol. 8, article 7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. A. T. McGill, J. M. Stewart, F. E. Lithander, C. M. Strik, and S. D. Poppitt, “Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity,” Nutrition Journal, vol. 7, no. 1, article 4, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. J. I. Botella-Carretero, F. Alvarez-Blasco, J. J. Villafruela, J. A. Balsa, C. Vázquez, and H. F. Escobar-Morreale, “Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity,” Clinical Nutrition, vol. 26, no. 5, pp. 573–580, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. N. M. Al-Daghri, K. M. Alkharfy, Y. Al-Saleh et al., “Modest reversal of metabolic syndrome manifestations with vitamin D status correction: a 12-month prospective study,” Metabolism, vol. 61, no. 5, pp. 661–666, 2011. View at Google Scholar
  31. J. A. Alvarez and A. Ashraf, “Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis,” International Journal of Endocrinology, vol. 2010, Article ID 351385, 18 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Liu, J. B. Meigs, A. G. Pittas et al., “Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults,” Journal of Nutrition, vol. 139, no. 2, pp. 329–334, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. H. L. Gulseth, I. M. F. Gjelstad, A. C. Tierney et al., “Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome,” Diabetes Care, vol. 33, no. 4, pp. 923–925, 2010. View at Google Scholar · View at Scopus
  34. M. F. Holick, “Vitamin D deficiency,” The New England Journal of Medicine, vol. 357, no. 3, pp. 266–281, 2007. View at Google Scholar
  35. F. R. Bringhurst, M. B. Demay, and H. M. Kronenberg, “Hormones and disorders of mineral metabolism,” in Williams Textbook of Endocrinology, H. M. Kronenberg, S. Melmed, K. S. Polonsky, and P. R. Larsen, Eds., pp. 1203–1268, Elsevier, Philadelphia, Pa, USA, 11 edition, 2008. View at Google Scholar
  36. T. J. Hahn, “Drug-induced disorders of vitamin D and mineral metabolism,” The Journal of Clinical Endocrinology & Metabolism, vol. 9, no. 1, pp. 107–127, 1980. View at Google Scholar
  37. M. J. Brodie, A. R. Boobis, C. J. Hillyard et al., “Effect of rifampicin and isoniazid on vitamin D metabolism,” Clinical Pharmacology and Therapeutics, vol. 32, no. 4, pp. 525–530, 1982. View at Google Scholar · View at Scopus
  38. S. J. Winters, R. Chennubhatla, C. Wang, J. J. Miller et al., “Influence of obesity on vitamin D-binding protein and 25-hydroxy vitamin D levels in African American and white women,” Metabolism, vol. 58, no. 4, pp. 438–442, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. H. F. DeLuca, “Overview of general physiologic features and functions of vitamin D,” The American Journal of Clinical Nutrition, vol. 80, supplement 6, pp. 1689S–1696S, 2004. View at Google Scholar
  40. M. F. Holick, E. S. Siris, N. Binkley et al., “Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 6, pp. 3215–3224, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Speroff and M. A. Fritz, Clinical Endocrinology and Infertility, Lippincott Williams and Wilkins, Philadelphia, Pa, USA, 2005.